Zosano Pharma Corporation (ZSAN)
| Market Cap | 109.21M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -34.21M |
| Shares Out | 77.88M |
| EPS (ttm) | -0.73 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | March 8 |
| Last Price | $1.12 |
| Previous Close | $1.07 |
| Change ($) | 0.05 |
| Change (%) | 4.21% |
| Day's Open | 1.08 |
| Day's Range | 1.04 - 1.19 |
| Day's Volume | 3,853,782 |
| 52-Week Range | 0.33 - 3.06 |
FREMONT, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its president and chief executive ...
FREMONT, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that the company has received the offici...
Zosano Pharma (ZSAN) stock is flying high on Tuesday with heavy trading despite there being a lack of news about the company. The post ZSAN Stock: 9 Things to Know About Zosano Pharma as Share...
FREMONT, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that early onset of action data for Qtry...
Zosano Pharma (ZSAN) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
News that migraine-treatment maker Zosano Pharma will reapproach the FDA for approval has ZSAN stock jumping this morning. Investors should be cautious as penny stocks can cause big headaches.
FREMONT, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that on December 30, 2020 the company re...
FREMONT, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its president and chief executive o...
LOS ANGELES--(BUSINESS WIRE)---- $ZSAN #ZSAN--DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Zosano Pharma Corporation.
New York, New York--(Newsfile Corp. - December 28, 2020) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Zosano Pharma Corporation ("...
New York, New York--(Newsfile Corp. - December 28, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) b...
NEW YORK--(BUSINESS WIRE)--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Zosano Pharma Corporation ("Zosano" or the "Company") (NASDA...
New York, New York--(Newsfile Corp. - December 26, 2020) - Pomerantz LLP announces that a class action lawsuit has been filed against Zosano Pharma Corporation ("Zosano" or the "Company") (NAS...
NEW YORK, Dec. 25, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in th...
New York, New York--(Newsfile Corp. - December 24, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secu...
NEW YORK, Dec. 24, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) between February 13,...
New York, New York--(Newsfile Corp. - December 24, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Zosano Pharma Corporation (NAS...
New York, New York--(Newsfile Corp. - December 23, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secu...
New York, New York--(Newsfile Corp. - December 23, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) b...
New York, New York--(Newsfile Corp. - December 22, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secu...
Investors with losses are encouraged to contact the firm before December 28, 2020 ; click here to submit trade information
NEW YORK--(BUSINESS WIRE)-- #ClassAction--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the ...
NEW YORK, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Zosano Pharma Corporation (NA...
New York, New York--(Newsfile Corp. - December 21, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secu...
NEW YORK, Dec. 19, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Zosano Pharma Corporation (“Zosano” or the “Company”) (NASDAQ: ZSAN) and ...
New York, New York--(Newsfile Corp. - December 17, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired sec...
New York, New York--(Newsfile Corp. - December 17, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) ...
New York, New York--(Newsfile Corp. - December 17, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Zosano Pharma Corporation (NAS...
LOS ANGELES, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming December 28, 2020 deadline to file a lead plaintiff motion in the class act...
NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) between February...
New York, New York--(Newsfile Corp. - December 15, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired sec...
NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Zosano Pharma Corporation (NA...
New York, New York--(Newsfile Corp. - December 14, 2020) - Pomerantz LLP announces that a class action lawsuit has been filed against Zosano Pharma Corporation ("Zosano" or the "Company") (NAS...
LOS ANGELES, Dec. 14, 2020 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming December 28, 2020 deadline to file a lead plaintiff motion in the class action ...
NEW YORK, Dec. 13, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Zosano Pharma Corporation (“Zosano” or the “Company”) (NASDAQ: ZSAN) and ...
NEW YORK, Dec. 12, 2020 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Zosano Pharma Corporation (NASDAQ: ZSAN) between ...
NEW YORK, Dec. 10, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) between February 13,...
New York, New York--(Newsfile Corp. - December 10, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Zosano Pharma Corporation (NAS...
New York, New York--(Newsfile Corp. - December 9, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secur...
New York, New York--(Newsfile Corp. - December 8, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Zosano Pharma Corporation (NASD...
NEW YORK, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Zosano Pharma Corporation (NA...
NEW YORK, Dec. 07, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Zosano Pharma Corporation (“Zosano” or the “Company”) (NASDAQ: ZSAN) and ...
New York, New York--(Newsfile Corp. - December 7, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secur...
New York, New York--(Newsfile Corp. - December 7, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) be...
New York, New York--(Newsfile Corp. - December 4, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secur...
New York, New York--(Newsfile Corp. - December 3, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zosano Pharma Corporation (NASDAQ: ZSAN) b...
NEW YORK, Dec. 3, 2020 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Zosano Pharma Corporation ("Zosano" or the "Company") (NASDAQ: ZSAN) and certa...
New York, New York--(Newsfile Corp. - December 1, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired secu...
LOS ANGELES, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming December 28, 2020 deadline to file a lead plaintiff motion in the class act...
NEW YORK, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Zosano Pharma Corporation (“Zosano” or the “Company”) (NASDAQ: ZSAN) and ...
About ZSAN
Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics to patients suffering from migraine using its intracutaneous microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.
| Industry Biotechnology | IPO Date Jan 27, 2015 |
| CEO Steven Lo | Employees 56 |
| Stock Exchange NASDAQ | Ticker Symbol ZSAN |
Analyst Forecasts
According to 3 analysts, the average rating for Zosano Pharma stock is "Buy." The 12-month stock price forecast is 1.83, which is an increase of 64.13% from the latest price.